Fitness Trends Ursodeoxycholic Acid Market | Seite 2

Opportunity Map (COM)
• Ursodeoxycholic Acid Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Ursodeoxycholic Acid Market, By Regions
• Ursodeoxycholic Acid Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Ursodeoxycholic Acid Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Ursodeoxycholic Acid Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Ursodeoxycholic Acid Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Increasing prevalence of gall stones and cystic fibrosis is expected to drive growth of the
ursodeoxycholic acid market
Ursodeoxycholic acid is increasingly being used for the treatment of chronic cholestatic liver
diseases. Increasing prevalence of cystic fibrosis and gall stones is a major factor driving growth
of the global ursodeoxycholic acid market during the forecast period. According to the Cystic
Fibrosis Foundation 2015 data, around 30,000 people suffered from cystic fibrosis in the U.S.
Moreover, around 1,000 new cases of cystic fibrosis are diagnosed in the country, annually.
According to the American Gastroenterological Association 2017 report, gallstones is affecting
10-15% of the U.S. population annually, which accounts for around 25 million people.
Women are more likely to develop gallstones in comparison to men. High estrogen levels during
pregnancy, birth control pills or hormone replacement therapy are the major factors that
produce gallstones in women. Moreover, occurrence of gallstones is also high in older adults
and individuals with a family history of gallstones. Surgery is the usual treatment for
symptomatic gallstones, however treatment with ursodeoxycholic acid can dissolve smaller
stones, which are made mainly of cholesterol.